Absence of fenfluramine-induced anorexia and reduced c-fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice

Journal of Neuroscience

Volumn 18, Issue 14, 1998, Pages 5537-5544

  Lucas, José J ^a,c   Yamamoto, Ai ^a   Scearce Levie, Kimberly ^a   Saudou, Frédéric ^b   Hen, René ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Bed nucleus of the stria terminalis; Central amygdaloid nucleus; Feeding; Fenfluramine; Fos; Knock out mice; Paraventricular nucleus of the hypothalamus; RU24969; Serotonin 1B receptor

Indexed keywords

5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; FENFLURAMINE; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARTICLE; CONTROLLED STUDY; HYPOPHAGIA; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MOUSE; NONHUMAN; OBESITY; ONCOGENE C FOS; PRIORITY JOURNAL; STRIA TERMINALIS; THALAMUS MIDLINE NUCLEUS;

EID: 0032527896     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-14-05537.1998     Document Type: Article

References (69)

1. Alheid GF, de Olmos JS, Beltramino CA (1995) Amygdala and extended amygdala. In: The rat nervous system, Ed 2 (Paxinos G, ed), pp 495-500. London: Academic.
2. Blundell JE, Latham CJ (1980) Characterization of adjustments to the structure of feeding behavior following pharmacological treatment: effects of amphetamine and fenfluramine and the antagonism produced by pimozide and methergoline. Pharmacol Biochem Behav 12:717-722.
3. Borsini F, Rolls ET (1984) Role of adrenaline in the basolateral region of the amygdala in food preferences and learned tasted aversion in rats. Int J Obes 11:141-155.
4. Boschert U, Aït Amara D, Segu L, Hen R (1993) The mouse 5-hydroxytryptamine 1B receptor is localized predominantly on axon terminals. Neuroscience 58:167-182.
5. 1B binding sites in the rat brain. Naunyn-Schmiedebergs Arch Pharmakol 347:569-582.
6. Bruinvels AT, Brancheck TA, Landwehrmeyer B, Mengod G, Hoyer D, Palacios JM (1994) Localisation of 5-HT1B, 5-HT1Da, 5-HT1E, and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33:367-386.
7. Brunner D, Hen R (1997) Insights in neurobiology of impulsive behavior from serotonin knockout mice. In: The neurobiology of suicide: from the bench to the clinic (Stoff DM, Mann JJ, eds), pp 81-105. New York: New York Academy of Sciences.
8. Callaway CW, Wing LL, Nichols DE, Geyer MA (1993) Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release. Psychopharmacology 111:169-178.
9. Cameron DL, Williams JT (1994) Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J Neurosci 14:6733-6767.
10. Cheetham SC, Heal DJ (1993) Evidence that RU24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptor. Br J Pharmacol 110:1621-1629.
11. Crabbe J, Phillips T, Feller D, Hen R, Wenger C, Lessov C, Schafer G (1996) Elevated alcohol consumption in null knockout mice lacking 5-HT1B receptors. Nat Genet 13:98-101.
12. Curzon G, Gibson EL, Oluyomi AO (1997) Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol Sci 18:21-25.
13. Davis R, Faulds D (1996) Dexfenfluramine. An updated review of its therapeutic use in the management of obesity. Drugs 52:696-724.
14. de Olmos JS (1969) A cupric-silver method for the impregnation of terminal axon degeneration and its further use in staining granular agryphilic neurons. Brain Behav Evol 2:213-237.
15. de Olmos JS (1972) The amygdaloid projection field in the rat as studied with the cupric-silver staining method. In: The neurobiology of the amygdala (Eleftheriou BE, ed), pp 145-204. New York: Plenum.
16. Dietel M (1997) Debate over dexfenfluramine. Can Med Assoc J 157:14.
17. Dourish CT (1992) 5-HT and ingestive behavior. In: Central serotonin receptors and psychotropic drugs (Marden CA, Heal DJ, eds), pp 260-291. London: Blackwell Scientific.
18. Fletcher PJ, Currie PJ, Chambers JW, Coscina, DV (1993) Radiofrequency lesions of the PVN fail to modify the effects of serotonergic drugs on food intake. Brain Res 630:1-9.
19. Garattini S, Mennini T, Samanin R (1989) Central serotonergic mechanisms and feeding regulation. In: Neurochemical pharmacology: a tribute to B. B. Brodle (Costa E, ed), pp 89-106. New York: Raven.
20. Garrow J (1991) Importance of obesity. Br Med J 303:704-706.
21. Gibson EL, Kennedy AJ, Curzon G (1993) D-fenfluramine and D-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors. Eur J Pharmacol 242:83-90.
22. Grignaschi G, Samanin R (1992) Role of 5-HT receptors in the effect of d-fenfluramine on feeding patterns in the rat. Eur J Pharmacol 212:287-289.
23. Grignaschi G, Sironi F, Samanin R (1995) The 5-HT1B receptor mediates the effect of d-fenfluramine on eating caused by intra-hypothalamic injection of neuropeptide Y. Eur J Pharmacol 274:221-224.
24. Guy-Grand B (1995) Clinical studies with dexfenfluramine: from past to future. Obes Res [Suppl] 4:491S-496S.
25. Hisano S, Uemura N, Fukui Y, Miki M, Zhang R (1994) Induction of Fos-like immunoreactivity in the rat hypothalamus by an endogenous feeding suppressant (2-buten-4-olide). Neurosci Lett 182:80-82.
26. Hoyer D, Middlemiss DN (1989) Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol Sci 10:130-132.
27. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.
28. Hutson PH, Donohow TP, Curzon G (1988) Infusion of the 5-hydrozytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus the hypothalamus causes hypophagia. Psychopharmacology 95:550-552.
29. Johnson SW, Mercuri NB, North RA (1992) 5-hydroxytryptamine 1B receptors block the GABAB synaptic potential in rat dopamine neurons. J Neurosci 12:2000-2006.
30. Kennett GA, Curzon G (1988) Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU24969 requires only 5-HT1B receptors. Psychopharmacology 96:93-100.
31. Kennett GA, Dourish CT, Curzon G (1987) 5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol 141:429-435.
32. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL (1994) Increasing prevalence of overweight among US adults. The national health and nutrition examination surveys, 1960 to 1991. J Am Med Assoc 272:205-211.
33. Kyrouli SE, Stanley BG, Seirafi RD, Leibowitz SF (1990) Stimulation of feeding by galanin-anatomical localization and behavioral specificity of this peptide effect in the brain. Peptides 11:995-1001.
34. Lee MD, Clifton PG (1992) Partial reversal of fluoxetine anorexia by the 5-HT antagonist metergoline. Psychopharmacology 107:359-364.
35. Lee MD, Simansky KJ (1997) CP-94,253: A selective serotonin 1B (5-HT1B) agonist that promotes satiety. Psychopharmacology 131:264-270.
36. Leibowitz SF (1992) Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. Trends Neurosci 15:491-497.
37. Leibowitz SF, Weiss GF, Suh JS (1990) Medial hypothalamic nuclei mediate serotonin's inhibitory effect on feeding behavior. Pharmacol Biochem Behav 37:735-742.
38. Li B-H, Rowland NE (1993) Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats. Brain Res Bull 31:43-48.
39. Lucas JJ, Hen R (1995) New players in the 5-HT receptor field: genes and knockouts. Trends Pharmacol Sci 16:246-252.
40. Lucas JJ, Segu L, Hen R (1997) 5-HT1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-HT1B knockout mice and the 5-HT1B/1D antagonist GR127935. Mol Pharmacol 51:755-763.
41. Ma QP, Yin GF, Ai MK, Han HS (1991) Serotoninergic projections from the nucleus raphe dorsalis to the amygdala in the rat. Neurosci Lett 134:21-24.
42. Menini T, Bizzi A, Caccia S, Codegoni A, Fracasso C, Fritolli E, Guiso G, Padura IM, Taddei C, Uslenghi A, Garattini S (1991) Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs. Naunyn-Schmiedelbergs Arch Pharmakol 343:483-490.
43. Morgan JI, Curran T (1991) Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 14:421-451.
44. Morris BJ (1989) Neuronal localization of neuropeptide Y gene expression in rat brain. J Comp Neurol 290:358-368.
45. Neill JC, Cooper SJ (1989) Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology 97:213-218.
46. Newman R (1997) Mitral valve disease associated with use of anorexigenic medications. Ann Thorac Surg 64:294.
47. Oberlander C, Blaquiere B, Pujol JF (1986) Distinct functions for dopamine and serotonin in locomotor behavior: evidence using the 5-HT1 agonist RU 24969 in globus pallidus-lesioned rats. Neurosci Lett 67:113-118.
48. Ramboz S, Saudou F, Aït Amara D, Beizung C, Misslin F, Segu L, Buhot M-C, Hen R (1996) 5-HT1B receptor knockout: physiological and behavioral consequences. Behav Brain Res 73:305-312.
49. Richard D, Rivest S, Rivier C (1992) The 5-hydroxytryptamine agonist fenfluramine increases Fos-like immunoreactivity in the brain. Brain Res 594:131-137.
50. Rocha BA, Scearce-Levie K, Lucas JJ, Hiroi N, Castanon N, Chen J, Gardner EL, Crabbe JC, Nestler EJ, Hen R (1998) Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 393:175-178.
51. Rouillard C, Bovetto S, Gervais J, Richard D (1996) Fenfluramine-induced activation of the immediate early gene c-fos in the striatum: possible interaction between serotonin and dopamine. Mol Brain Res 37:105-115.
52. Sagar SM, Sharp FR, Curran T (1989) Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240:1328-1331.
53. Saudou F, Aït Amara D, LcMeur M, Ramboz S, Segu L, Buhot M, Hen R (1994) Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265:1875-1878.
54. Sawchenko PE, Swanson LW, Steinbusch HWM, Verhofstad AAJ (1983) The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res 277:355-360.
55. Schoenen J (1997) Acute migraine therapy: the newer drugs. Curr Opin Neurol 10:237-243.
56. Schwaber JS, Kapp BS, Higgins GA, Rapp PR (1982) Amygdaloid and basal forebrain direct connections with the nucleus of solitary tract and the dorsal motor nucleus. J Neurosci 2:1424-1438.
57. Shukla R, MacKenzie-Taylor D, Rech RH (1990) Evidence for 5-HT2 receptor mediation in quipazine anorexia. Psychopharmacology 100:115-118.
58. Silverstone T (1992) Appetite suppressants. A review. Drugs 43:820-836.
59. Simansky KJ (1996) Serotonergic control of the organization of feeding and satiety. Behav Brain Res 73:37-42.
60. Stark KL, Ghavami A, Segu L, Mayford M, Kandel E, Hen R (1997) Inducible knockout and tissue-specific rescue of the 5-HT1B receptor. Soc Neurosci Abstr 23:116.
61. Takaki A, Nagai K, Takaki S (1990) Satiety function of neurons containing a CCK-like substance in the dorsal parabrachial nucleus. Physiol Behav 48:865-871.
62. Verbalis JG, Stricker EM, Robinson AG, Hoffman GE (1991) Cholecystokinin activates c-fos in hypothalamic oxytocin and corticotropin-releasing hormone neurons. J Neuroendocrinol 3:205-213.
63. Vickers SP, Clifton PG, Dourish CT (1996) Behavioral evidence that d-fenfluramine-induced anorexia in the rat is not mediated by the 5HT-1A receptor subtype. Psychopharmacology 125:168-175.
64. Waeber C, Palacios JM (1989) Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington's chorea but not in Parkinson's disease: a quantitative in vitro autoradiography study. Neuroscience 32:337-347.
65. Weingarten HP, Chang P, McDonald TJ (1985) Comparison of the metabolic and behavioral disturbances following paraventricular- and ventromedial-hypothalamic lesions. Brain Res Bull 14:551-559.
66. Weiss GF, Rogacki N, Fueg A, Buchen D, Leibowitz SF (1990) Impact of hypothalamic D-norfenfluramine and peripheral D-fenfluramine injection on macronutrient intake in the rat. Brain Res Bull 25:849-859.
67. Weiss GF, Rogacki N, Fueg A, Suh JS, Wong DT, Leibowitz SF (1991) Effect of hypothalamic and peripheral fluoxetine injection on natural patterns of macronutrient intake in the rat. Psychopharmacology 105:467-476.
68. Wyrwicka W (1992) Brain and feeding behavior. Springfield, II: Thomas.
69. Yu X-J, Waeber C, Castanon N, Scearce K, Hen R, Macor J, Moskowitz M (1996) Knockout mice lacking 5-HT1B receptors: 5-carboxamidotryptamine, CP-122,288 and dihydroergotamine, but not sumatriptan, CP-93,129 or serotonin-5-O-carboxymethyl-glycyl-tyrosinamide block dural plasma protein extravastion. Mol Pharmacol 49:761-765.